Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients
Cancer · 2025
DOI: 10.1002/cncr.70183 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer, 2025. Verfasst von Wenyu Shi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Marginal Zone, Thymus Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Postgraduate Research and Practice Innovation Program of Jiangsu Province, Clinical Capacity Enhancement Project.
Abstract (Originalsprache)
Background
The systemic study of thymic mucosa‐associated lymphoid tissue (MALT) lymphoma remains lacking. The objective of this study was to characterize the clinical features and outcomes of patients with thymic MALT lymphoma.
Methods
The authors conducted a retrospective analysis of patients with thymic MALT lymphoma who were diagnosed at multiple medical centers in China from 2011 to 2024. Clinical, laboratory, therapeutic, and survival data were collected.
Results
In total, 82 patients were included. The median age of the cohort was 47 years with a female predominance (female/male ratio = 5.3:1.0). Eighty‐two percent of patients presented with limited stage disease. Forty‐one patients had a definitive diagnosis of autoimmune disease, with Sjogren's syndrome being the most common ( n = 37). Antinuclear antibodies were positive in 42 of 44 (95%) of examined patients. Management strategies included watch and wait (2%), local therapy alone (surgery, radiotherapy, or both; 71%), a combination of local and systemic therapy (26%), or systemic therapy alone (1%). With a median follow‐up of 2.7 years, the 2‐year progression‐free and overall survival rates for the entire cohort were 98.6% (95% confidence interval, 95.8%–100.0%) and 100% (95% confidence interval, 100.0%–100.0%), respectively. Patients treated with local therapy alone ( n = 58) and those who received local and systemic therapy ( n = 21) had similar progression‐free survival ( p = .530). Patients who underwent surgery alone ( n = 53) had a 2‐year progression‐free survival rate of 100% (95% confidence interval, 100.0%–100.0%).
Conclusions
Patients with thymic MALT lymphoma have an excellent prognosis. Sjogren’s syndrome is closely associated with thymic MALT lymphoma. Routine screening for autoimmune disorders and surgical resection are recommended for patients who have newly diagnosed thymic MALT lymphomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Hematology, Lymphoma Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Radiation Oncology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Wenyu Shi, Hongling Peng, Lei Fan, Wenjuan Yu, Yi Miao
Förderung
- Postgraduate Research and Practice Innovation Program of Jiangsu Province
- Clinical Capacity Enhancement Project
Zitieren
APA
Shi, W., Ren, Y., Liu, S., Liu, Y., Xia, Y., Li, S., Wang, X., Zhang, L., Guo, X., He, L., Peng, H., Zhang, Y., Liu, Y., Fan, L., Sun, X., Li, J., Yu, W., Feng, X., & Miao, Y. (2025). Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients. Cancer. https://doi.org/10.1002/cncr.70183
Vancouver
Shi W, Ren Y, Liu S, Liu Y, Xia Y, Li S, et al. Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients. Cancer. 2025. doi:10.1002/cncr.70183
BibTeX
@article{Shi2025,
author = {Shi, Wenyu and Ren, Yimin and Liu, Shu and Liu, Yanping and Xia, Yi and Li, Siyuan and Wang, Xiaojun and Zhang, Lu and Guo, Xutao and He, Lu and Peng, Hongling and Zhang, Ya and Liu, Yanyan and Fan, Lei and Sun, Xinchen and Li, Jianyong and Yu, Wenjuan and Feng, Xiaoli and Miao, Yi},
title = {Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.70183}
}
EUVIMED